Image

larger text    
    


 		  
  • About APIC
  • Member Services
  • Education & Certification
  • Research Foundation
  • Guidelines & Standards
  • Public Policy
  • Resources/Information Services
    
 
 
Email this Page
Home > Practice Guidance > ID Center > Plague
News  |  Overview  |  Clinical Pathway  |  Resource List  |  Selected Reading

Plague

Latest News New on the Site
Oct 16
US funds work on drugs for plague, tularemia, anthrax
Mar 30
Study: Drug-resistant plague may signal health threat
Dec 11, 2006
CDC rates hospital bioterrorism preparedness
Oct 19, 2006
Suspected plague killed 42 in Congo, WHO says
Jun 26, 2006
Aid group seeks help fighting plague in Congo
Jun 14, 2006
Suspected plague kills 100 in Congo, WHO says
Aug 19, 2005
Research sheds light on plague agent and potential vaccine
May 27, 2005
Plague outbreak highlighted ongoing problem in Africa
Apr 21, 2005
US, UK, Canada to jointly test plague vaccines
Mar 15, 2005
WHO reports 130 suspected plague cases in Congo
Mar 4, 2005
57 plague cases found in Congo, WHO reports
Mar 2, 2005
Congo's plague outbreak smaller than initially feared
Feb 18, 2005
Pneumonic plague outbreak in Congo sparks WHO response
Sep 15, 2004
Plague organism shed genes as it grew more lethal
Aug 2, 2004
Ongoing plague outbreak reported in Congo
Mar 25, 2004
Vaccine prevents flea-borne plague in mice
Jan 17, 2003
Report of missing plague specimens in Texas was false alarm
May 2, 2002
Single gene change enabled plague bacterium to ride in fleas
Oct 17, 2001
Plague genome suggests organism evolved from gut to blood pathogen
    
Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague
From Mar 20 Vaccine

Characterization of Yersinia pestis isolates from natural foci of plague in the Republic of Georgia and their relationship to Y pestis isolates from other countries
From Clin Microbiol Infect, published online Feb 21

yadBC of Yersinia pestis, a new virulence determinant for bubonic plague
From Feb Infect Immun

Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein
From Feb Infect Immun

Plague: past, present, and future
From Jan 15 PLoS Med

Plague: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, and treatment
Comprehensive CIDRAP-authored overview, updated Nov 1 with new research
Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis
From Nov 2 PLoS Pathog

Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity
From Oct 16 Vaccine

Comparison of hand-held test kits, immunofluorescence microscopy, ELISA, and flow cytometric analysis for rapid presumptive identification of Yersinia pestis
From Oct J Clin Microbiol

Plague reemergence in Algeria after 50 years, 2003
From Emerg Infect Dis, published online Aug 24

Climatically driven synchrony of gerbil populations allows large-scale plague outbreaks
From Aug 22 Proc Biol Soc

Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy
From Aug Antimicrob Agents Chemother

Yersinia pestis CO92(delta)yopH is a potent live-attenuated plague vaccine
From Clin Vaccine Immunol, published online Jul 25

A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen
From FEMS Immunol Med Microbiol, published online Jul 19

Residence-linked human plague in New Mexico: a habitat-suitability model
From Jul Am J Trop Med Hyg

Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague
From J Infect Dis, published online Jul 19

Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy
From Aug Antimicrob Agents Chemother

Plague: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, and treatment
CIDRAP-authored overview, updated Jul 6 with new research
Evaluation of combinatorial vaccines against anthrax and plague in a murine model
From Jun 11 Vaccine

 

Provided by the Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota.


Sponsored through an educational grant from BD

 

APIC does not endorse or recommend the products or services of any commercial entity.
Association for Professionals in Infection Control and Epidemiology, Inc. 
1275 K St., NW, Suite 1000, Washington, DC, 20005-4006 (p) 202.789.1890 (f) 202.789.1899
apicinfo@apic.org |  Privacy Policy   |  Terms of Use